Top

Published in:

01-07-2005 | Regular Paper

α-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy

Authors: Mie Sone, Mari Yoshida, Yoshio Hashizume, Nozomi Hishikawa, Gen Sobue

Published in: Acta Neuropathologica | Issue 1/2005

Abstract

We immunohistochemically examined the sympathetic ganglia (SG) and brains of 26 patients with multiple system atrophy (MSA), 19 age-matched controls, and 25 patients with amyotrophic lateral sclerosis (ALS). α-Synuclein-immunoreactive structures were found in the neuronal cytoplasm and processes of the SG in 11 of the 26 MSA cases (42.3%) and 1 of the 25 ALS cases (4%), but not in the 19 controls. No α-synuclein-immunoreactive structures were found in Schwann cells or the neuronal nucleus. Mean disease duration of MSA cases with α-synuclein-immunoreactive structures was significantly longer than that of MSA cases without α-synuclein-immunoreactive structures. α-Synuclein-immunoreactive structures in 4 cases proved to be Lewy bodies (LB) based on hematoxylin-eosin staining. A few LB were also found in the brains of 3 of these 4 cases. In the other 7 MSA cases, diffuse or focal neuronal cytoplasmic aggregates and swollen neurites were detected with α-synuclein immunostaining, but not with hematoxylin-eosin staining. However, a few LB-like structures with ring-like staining were observed in those aggregates, which suggested those aggregates had progressed to form LB. Immunoelectron microscopically, those aggregates were composed of filaments and granular materials which closely resembled the ultrastructural features of LB. We inferred that α-synuclein aggregates found in the SG in our study evidenced LB-related pathologies. MSA, a type of synucleinopathy, is characterized by glial cytoplasmic inclusions in oligodendrocytes, but also frequently develops LB pathology in the late stage, especially in the SG.

Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, Tonozuka-Uehara H, Kawai M (1998) NACP/α-synuclein imunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in pontine nuclei in multiple system atrophy. Acta Neuropathol 96:439–444CrossRefPubMed

Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M (1998) Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson’s disease and in dementia with Lewy bodies. Brain Res 808:93–100CrossRefPubMed

Braak H, Del Tredici K, Rüb U, De Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 34:197–211CrossRef

Daniel S (1999) The neuropathology and neurochemistry of multiple system atrophy. In: Matias C, Bannister R (eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford, pp 321–328

Del Tredici K, Rüb U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426PubMed

Dickson DW, Liu W-K, Hardy J, Farrer M, Mehta N, Uitti R, Mark M, Zimmerman T, Golbe L, Sage J, Sima, D’Amato C, Albin R, Gilman S, Yen S-H (1998) Widespread alterations of α-synuclein in multiple system atrophy. Am J Pathol 155:1241–1251

Dickson DW, Lin W, Liu W-K, Yen S-H (1999) Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 9:721–732PubMed

Gai WP, Power JHT, Blumbergs PC, Blessing WW (1998) Multiple-system atrophy: a new α-synuclein disease? Lancet 352:547–548CrossRefPubMed

Gai WP, Pountney DL, Power JHT, Li QX, Culvenor JG, McLean CA, Jensen PH, Blumbergs PC (2003) α-Synuclein fibrils constitute the central core of oligodendroglia inclusion filaments in multiple system atrophy. Exp Neurol 181:68–78CrossRefPubMed

10.

Galvin JE, Lee VM-Y, Trojanowski JQ (2001) Synucleinopathy: clinical and pathological implications. Arch Neurol 58:186–190CrossRefPubMed

11.

Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98CrossRefPubMed

12.

Graham JG, Oppenheimer DR (1969) Orthostatic hypertention and nicotine insensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32:28–34PubMed

13.

Hayashida K, Oyanagi S, Mizutani Y, Yokochi M (1993) An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism. Acta Neuropathol 85:445–448CrossRefPubMed

14.

Hishikawa N, Hashizume Y, Yoshida M, Sobue Gen (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson’s disease. Appl Neurobiol 27:362–372CrossRef

15.

Hishikawa N, Hshizume Y, Yoshida M, Sobue Gen (2003) Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol 105:341–350

16.

Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihara M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body disease. Neurology 52:1269–1271PubMed

17.

Jellinger KA (2003) α-Synuclein pathology in Parkinson’s and Alzheimer’s desease brain: incidence and topographic distribution—a pilot study. Acta Neuropathol 106:191–201CrossRefPubMed

18.

Jellinger KA (2003) Neuropathological spectrum of synucleinopathy. Mov Disord 18 (Suppl 6):S2–S12CrossRefPubMed

19.

Kato S, Nakamura H (1990) Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. Acta Neuropathol 79:584–594CrossRefPubMed

20.

Kawasaki H, Shimada H, Tomonaga M (1988) Morphological study on the Lewy bodies in the sympathetic ganglia of the aged persons (in Japanese). Nippon Ronen Igakkai Zasshi 25:282–291PubMed

21.

Lantos PL (1998) The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 57:1099–1111PubMed

22.

Lowe J, Leigh N (2003) Disorders of movement and system degenerations. In: Graham D, Lantos PL (eds) Greenfield’s neuropathology, 7th edn, vol 2. Arnord, London, pp 343–346

23.

Nakazato Y, Yamazaki H, Hirato J, Ishida Y, Yamaguchi H (1999) Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 57:690–698

24.

Neuropathology groups of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS) (2001) Pathological correlate of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357:169–175CrossRefPubMed

25.

Nishie M, Mori F, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, Takahashi H, Wakabayashi K (2004) Accumulation of phosphorylated α-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol 107:292–298CrossRefPubMed

26.

Papp MI, Lantos PL (1992) Accumulation tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 107:172–182CrossRefPubMed

27.

Papp MI, Lantos PL (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 117:235–243PubMed

28.

Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79–100CrossRefPubMed

29.

Parikh SM, Diedrich A, Biaggioni I, Robertson D (2002) The nature of autonomic dysfunction in multiple system atrophy. J Neurol Sci 200:1–10CrossRefPubMed

30.

Parkkinen L, Soininen H, Laakso M, Alafuzoff I (2001) α-Synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol 27:314–325CrossRefPubMed

31.

Riku S, Hashizume Y (1984) A clinico-pathological study on multiple system atrophy, with special reference to its striato-nigral lesions and motor neuron involvements (in Japanese). Rinsyou Shinkei 24:552–561

32.

Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouti H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated α-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644–654PubMed

33.

Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 251:205–208CrossRefPubMed

34.

The Consensus Committee of the American Autonomic Society and the American Academy of Neurology (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 46:1470PubMed

35.

Tu P-H, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM-Y (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insolubleα-synuclein. Ann Neurol 44:415–422CrossRefPubMed

36.

Wakabayashi K (1989) Parkinson’s disease: the distribution of Lewy bodies in the peripheral autonomic nervous system (in Japanese). No To Shinkei 41:965–971PubMed

37.

Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson’s disease. Eur Neurol 38 (Suppl 2):2–7

38.

Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180–182CrossRefPubMed

39.

Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H (1998) Accumulation of NACP/α-synuclein is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 96:445–452CrossRefPubMed

40.

Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1995) Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 58:160–166PubMed

41.

Wenning GK, Seppi K, Tison F, Jellinger K (2002) A novel grading scale for striatonigral degeneration (multiple system atrophy) J Neural Transm 109:307–320

42.

Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3:93–103CrossRefPubMed

Title: α-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy
Authors: Mie Sone
Mari Yoshida
Yoshio Hashizume
Nozomi Hishikawa
Gen Sobue
Publication date: 01-07-2005
Publisher: Springer-Verlag
Published in: Acta Neuropathologica / Issue 1/2005
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-005-1013-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

α-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2005

Distribution of cerebral cortical lesions in diffuse neurofibrillary tangles with calcification: a clinicopathological study of four autopsy cases showing prominent parietal lobe involvement

Spindle cell oncocytoma of the adenohypophysis: report of two cases

Frontotemporal dementia, motor neuron disease and tauopathy: clinical and neuropathological study in a family

Cerebellopontine calcification: a new entity of idiopathic intracranial calcification?

Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene

Exon 3 insert of tau protein in neurodegenerative diseases